|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400080093 |
|
最近更新日期: Date of Last Refreshed on: |
2024-01-19 15:37:34 |
|
注册时间: Date of Registration: |
2024-01-19 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
中青年宫颈癌手术患者线上心理康复成长营的项目设计与评估 |
|
Public title: |
Effectiveness of an Internet-based psychological rehabilitation programme of postoperative middle-aged and young adults with cervical cancer : A randomized controlled trial |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
青年子宫颈上皮内瘤变手术患者一体化健康管理的项目设计与效果评价 |
|
Scientific title: |
Project design and effectiveness evaluation of integrated health management for young patients undergoing cervical intraepithelial neoplasia surgery |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
谢颖 |
研究负责人: |
谢颖 |
|
Applicant: |
Ying Xie |
Study leader: |
Ying Xie |
|
申请注册联系人电话: Applicant telephone: |
+86 159 0773 2202 |
研究负责人电话:
Study leader's |
+86 159 0773 2202 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
33240013@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
33240013@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
广西桂林七星区环城北二路109号 |
研究负责人通讯地址: |
广西桂林七星区环城北二路109号 |
|
Applicant address: |
School of Nursing, Guilin Medical University, No. 109 Huancheng North Second Road, Guilin, Guangxi, China |
Study leader's address: |
School of Nursing, Guilin Medical University, No. 109 Huancheng North Second Road, Guilin, Guangxi, China |
|
申请注册联系人邮政编码: Applicant postcode: |
541000 |
研究负责人邮政编码: Study leader's postcode: |
541000 |
|
申请人所在单位: |
桂林医学院 |
||
|
Applicant's institution: |
Guilin Medical University |
||
|
研究负责人所在单位: |
桂林医学院 |
||
|
Affiliation of the Leader: |
Guilin Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
GYLL2022058 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
桂林医学院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Guilin Medical College |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-01-10 00:00:00 | ||
|
伦理委员会联系人: |
蒋伟 |
||
|
Contact Name of the ethic committee: |
Wen Jiang |
||
|
伦理委员会联系地址: |
广西桂林市临桂区致远路1号 |
||
|
Contact Address of the ethic committee: |
Guilin Medical University, No. 1 Zhiyuan Road, Guilin, Guangxi, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 773 589 2229 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
桂林医学院附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Affiliate Hospital of Guilin Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广西桂林市秀峰区乐群路15号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Affiliate Hospital of Guilin Medical University, No. 15 Lequn Road, Guilin, Guangxi, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
桂林医学院中青年教职工科研能力提升项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
Young and middle-aged faculty research ability improvement project of Guilin Medical University |
||||||||||||||||||||||
|
研究疾病: |
宫颈癌 |
||||||||||||||||||||||
|
Target disease: |
cervical cancer |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
I期临床试验 | ||||||||||||||||||||||
|
Study phase: |
1 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
早期宫颈癌以手术治疗为主,术后五年存活率超过90%。手术给患者带来希望的同时,也损伤了患者完整的盆底结构,给中青年女性带来极大心理痛苦。中青年宫颈癌患者因其心理承受能力的脆弱性,在治疗期间承受着更大的心理压力,但目前很少关注中青年宫颈癌患者的心理防护。因此,本研究旨在探讨线上心理康复成长营对中青年宫颈癌术后患者心理痛苦程度、盆底肌恢复及社会交往需求的作用效果。 |
||||||||||||||||||||||
|
Objectives of Study: |
Early cervical cancer is mainly treated with surgery, and the five-year survival rate after surgery exceeds 90%. Surgery not only brings hope to patients, but also damages their complete pelvic floor structure, bringing great psychological pain to middle-aged and young women. Young and middle-aged cervical cancer patients are facing greater psychological pressure during treatment due to their fragile psychological resilience. However, there is currently little attention paid to the psychological protection of young and middle-aged cervical cancer patients. Therefore, this study aims to explore the effect of online psychological rehabilitation growth camps on the psychological pain level, pelvic floor muscle recovery, and social interaction needs of middle-aged and young cervical cancer patients after surgery. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
符合国际妇产科联合会(FIGO)关于宫颈癌标准诊断,为IA~IIA期宫颈癌患者;年龄<45岁,有性生活史,均首次接受手术,未进行任何放疗和/或化疗者;躯体功能正常,具有一定表达能力;本地区常住人口;知情同意,能积极配合治疗者。 |
||||||||||||||||||||||
|
Inclusion criteria |
Biopsy-proven squamous cell Carcinoma, and the International Federation of Gynaecology and Obstetrics (FIGO) stage IA-IIA disease;age≤45 years;all patients underwent radical hysterectomy with pelvic lymph node dissection, no radiation and/or chemotherapy;could read and speak Chinese, had Normal physical activity restrictions;were able to use a computer and/or smartphone to access the Internet;Resident population in the local area; Informed consent, able to actively cooperate with the treatment provider. |
||||||||||||||||||||||
|
排除标准: |
妊娠期、哺乳期患者;复发性癌症,有严重的心脑血管、肺部和肝肾和血液系统等严重原发性疾病,或有精神病、心理疾病史。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Pregnant and lactating patients;recurrent cervical cancer, have had severe cardiovascular, pulmonary, and cerebral diseases, or had mental illness history. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-03-05 00:00:00至 To 2023-09-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-03-05 00:00:00 至 To 2023-03-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
获得参与者的口头同意,研究小组的一名成员就会联系每位参与者,提供进一步的研究信息并获得书面知情同意。通过使用计算机软件(Excel程序,微软公司)生成一系列随机数,我们将患者1:1随机分配到干预组和对照组中。参与者、数据分析师和研究人员都对随机分配视而不见,只有研究助理知道分配。本研究符合1975年《赫尔辛基宣言》的伦理准则。伦理批准取得桂林医学院附属医院(参考号:GYLL2022058)。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Once the participant's verbal consent was obtained, one of study team member approached each participant to provide further study information and obtain written informed consent. Through used computer software (Excel program, Microsoft Corp) to generate a series of random numbers, we randomly assigned patients 1:1 to one of intervention group and control group. Participants, data analysts, and investigators were all blinded to the randomized allocation, and only the research assistants were aware of the allocation. This study conformed to the ethical guidelines of the 1975 Declaration of Helsinki. Ethics approval was obtained from the Affiliated Hospital of Guiling Medical University (reference number: GYLL2022058). |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
试验完成6个月内公开数据(resman临床试验公共管理平台,http://www.medresman.org.cn/login.aspx) |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Within six mouths after the trail complete(Resman Clinical Trial Public Management Platform,http://www.medresman.org.cn/login.aspx) |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
研究者根据受试者原始观察记录,将数据完整、清晰、正确地录入病例报告,录入采用数据库系统双人双机录入,并对输入数据2遍核对,电子数据分类保存,并有多个备份保留至多个存储备,妥善保存,防止损坏。 目前,已在resman临床试验公共管理平台上传数据,并审核通过。http://www.medresman.org.cn/login.aspx |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Based on the original observation records of the subjects, the researchers entered the data into the case report in a complete, clear, and correct manner. The data was entered using a database system with two people and two machines, and the input data was checked twice. The electronic data was classified and saved, and multiple backups were kept to multiple storage devices, properly stored to prevent damage. At present, the data has been uploaded and approved on the Resman Clinical Trial Public Management Platform. http://www.medresman.org.cn/login.aspx |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |